Science Explorer Interactive view Map
Nonprofit · Geneva · Switzerland

Drugs for Neglected Diseases Initiative

In research, Drugs for Neglected Diseases Initiative stands highest in Medicine (#5,791 of 17,978 worldwide) and Health Sciences (#7,530 of 20,462 worldwide), over all time.

dndi.orgROR OpenAlex
World rank, all time
#14,561
of 42,892
Rank in Switzerland
#129
of 429
Research works
249
▲ 33% vs 2013–17
Citations
8.9k
35.7 per fractional work
Top-10% rate
26.5%
record average 16.5%
Open access
65%
world 28%

What is Drugs for Neglected Diseases Initiative known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #5,791 of 17,978 39.7%146
Health SciencesDomain #7,530 of 20,462 38.3%160

Each strip is that field’s whole ranked pool, with the notch where Drugs for Neglected Diseases Initiative sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.75× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.44× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 9.33× its world share, 6 worksImmunology and Micro…Neuroscience: 0.11× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.36× its world share, 2 worksPharmacology, Toxico…Chemistry: 2.15× its world share, 2 worksChemistryComputer Science: 0.11× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.07× its world share, 0 worksEarth and Planetary …Engineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.56× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.11× its world share, 0 worksMaterials ScienceMathematics: 0.71× its world share, 0 worksMathematicsDentistry: 0.17× its world share, 0 worksDentistryHealth Professions: 0.94× its world share, 1 worksHealth ProfessionsMedicine: 2.81× its world share, 31 worksMedicineNursing: 2.26× its world share, 1 worksNursingVeterinary: 21.31× its world share, 2 worksVeterinaryArts and Humanities: 0.08× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.74× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 0.48× its world share, 1 worksEconomics, Econometr…Psychology: 0.22× its world share, 0 worksPsychologySocial Sciences: 0.25× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 21.3×. Every wedge is a field page.

Who are the top researchers at Drugs for Neglected Diseases Initiative?

Ranked on the composite score, Jorge Alvar and Fabiana Alves lead among researchers whose main affiliation is Drugs for Neglected Diseases Initiative.

  1. 1 Jorge Alvar Switzerland · #154,358 worldwide 149 citations · 23 works
  2. 2 Fabiana Alves Switzerland · #507,332 worldwide 61 citations · 16 works
All ranked researchers at Drugs for Neglected Diseases Initiative

Which keywords describe research at Drugs for Neglected Diseases Initiative?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Drug Resistance, Diagnosis, Vaccine Development, Vector Control, Genome Sequence, Immunity and Treatment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology22▲ 9.6×39 topics
  2. Drug Resistance15▲ 91×6 topics
  3. Diagnosis9▲ 17×10 topics
  4. Vaccine Development8▲ 55×6 topics
  5. Vector Control8▲ 118×4 topics
  6. Genome Sequence8▲ 156×2 topics
  7. Immunity7▲ 31×3 topics
  8. Treatment7▲ 10×8 topics
  9. Chemotherapy7▲ 17×2 topics
  10. Chagas Disease7▲ 738×1 topic
  11. Trypanosoma cruzi7▲ 738×1 topic
  12. Leishmaniasis6▲ 562×1 topic
  13. Parasite6▲ 491×1 topic
  14. Helminth Infections6▲ 255×2 topics
  15. Global Epidemiology4▲ 151×2 topics
  16. Disease Burden4▲ 86×2 topics
  17. Schistosomiasis4▲ 229×1 topic
  18. Soil-Transmitted Helminths4▲ 229×1 topic
  19. Public Health3▲ 3.9×17 topics
  20. Ivermectin2▲ 162×2 topics
  21. Zoonotic Infections2▲ 69×2 topics
  22. Antifungal Therapy2▲ 40×3 topics
  23. Lymphatic Filariasis2▲ 313×1 topic
  24. Onchocerciasis2▲ 313×1 topic
  25. Pathogenesis2▲ 5.9×12 topics
  26. Synthesis2▲ 8.5×5 topics
  27. Medicinal Chemistry2▲ 11×3 topics
  28. Vaccine2▲ 7.3×8 topics
  29. Actinomycosis2▲ 461×1 topic
  30. Genomic Sequencing2▲ 24×2 topics
  31. Nocardia spp.2▲ 461×1 topic
  32. Drug Development2▲ 28×2 topics
  33. Biological Evaluation1▲ 42×3 topics
  34. Insecticide Resistance1▲ 30×3 topics
  35. Non-Communicable Diseases1▲ 8.2×2 topics
  36. SARS-CoV-21▲ 7.2×3 topics
  37. Anticancer1▲ 15×6 topics
  38. Anticancer Agents1▲ 14×3 topics
  39. Oomycetes1▲ 74×1 topic
  40. Virulence Factors1▲ 15×3 topics

Which research topics does Drugs for Neglected Diseases Initiative publish most on?

By volume in 2022–2025: Trypanosoma species research and implications, Research on Leishmaniasis Studies, Parasites and Host Interactions and Parasitic Diseases Research and Treatment.

Trypanosoma species rese…7Trypanosoma species research and implications: 7 fractional worksResearch on Leishmaniasi…6Research on Leishmaniasis Studies: 6 fractional worksParasites and Host Interactions: 4 fractional worksParasitic Diseases Research and Treatment: 2 fractional worksActinomycetales infectio…2Actinomycetales infections and treatment: 2 fractional worksInfectious Diseases and Mycology: 1 fractional worksGlobal Public Health Policies and Epidemiology: 1 fractional worksFungal Infections and Studies: 1 fractional worksSynthesis and Biological Evaluation: 1 fractional worksGlobal Maternal and Child Health: 1 fractional works
EpidemiologyPublic Health, Environmental and Occupational HealthParasitologyInfectious Diseases5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Trypanosoma species research and implications Epidemiology 7 works
  2. 2 Research on Leishmaniasis Studies Public Health, Environmental and Occupational Health 6 works
  3. 3 Parasites and Host Interactions Parasitology 4 works
  4. 4 Parasitic Diseases Research and Treatment Infectious Diseases 2 works
  5. 5 Actinomycetales infections and treatment Microbiology 2 works
  6. 6 Infectious Diseases and Mycology Small Animals 1 works
  7. 7 Global Public Health Policies and Epidemiology Organizational Behavior and Human Resource Management 1 works
  8. 8 Fungal Infections and Studies Epidemiology 1 works
  9. 9 Synthesis and Biological Evaluation Organic Chemistry 1 works
  10. 10 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.6%not open35.4%

World: 28% of research is openly available.

with international co-authors66.6%domestic only33.4%

World: 19% is written across borders.

How has Drugs for Neglected Diseases Initiative's research output changed?

Output in 2018–2022 was 33% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Geneva

All research institutions in Geneva

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.